Shukla Sath 4
4 · Spero Therapeutics, Inc. · Filed Aug 3, 2023
Insider Transaction Report
Form 4
Shukla Sath
CEO & President
Transactions
- Award
Common Stock
2023-08-01+266,000→ 578,517 total
Footnotes (1)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in four equal annual installments beginning on August 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date.